Health Sciences Acquisitions Corp 2 extends business combination deadline to February 6, 2023

Orchestra BioMed Holdings, Inc.

Company's directors elected to extend deadline to February 6, 2023, from prior extended date of November 6, 2022.
Extension approved by shareholders in July 2022; allows up to three monthly extensions without another vote.
If no business combination by Feb 6, 2023, company will cease operations, redeem shares, and liquidate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.